Myocardial revascularization: new randomized trialswith controversial results

Authors: Golukhova E.Z.

Company: A.N. Bakoulev Scientific Center for Cardiovascular Surgery of Ministry of Health of the Russian Federation; Rublevskoe shosse, 135, Moscow, 121552, Russian Federation


DOI: https://doi.org/10.15275/kreatkard.2016.04.01

For citation: Golukhova E.Z. Myocardial revascularization: new randomized trialswith controversial results. Creative Cardiology. 2016; 10 (4): 276-280 (in Russ.).

Full text:  

 

References

  1. Mäkikallio T., Holm N.R., Lindsay M., Spence M.S., Erglis A., Menown I.B., Christiansen E.H. et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet. 2016; 388 (10061): 2743–52. DOI: 10.1016/S0140-6736(16)32052-9.
  2. Stone G.W., Sabik J.F., Serruys P.W., Simonton C.A., Généreux P., Puskas J. et al. Everolimuseluting stents or bypass surgery for left main coronary artery disease. N. Engl. J. Med. 2016; 375 (23): 2223–35. DOI: 10.1056/NEJMoa1610227.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery